4.6 million doses of COVID-19 vaccine were wasted in India — enough to vaccinate half of Bangalore
- India has wasted 4.6 million doses of the COVID-19 vaccine since the vaccine drive began to April 11.
- Eight states, including Kerala, West Bengal and Goa, reported zero wastage.
- Tamil Nadu, on the other hand, has the highest vaccine waste rate of 12% followed by Haryana at 9%.
India has wasted 4.6 million doses so far since the drive to vaccinate the population kicked off in January, according to data shared by the Ministry of Health and Family Welfare (MoHFW) in response to a Right to Information (RTI) query.
4.6 million doses are enough to inoculate half of Bangalore. In a smaller city like Chandigarh, those doses are enough to vaccinate every citizen four times over.
AdvertisementThe RTI filed by Vivek Pandey and reported by NDTV also reveals that the state with the highest wastage was Tamil Nadu, followed by Haryana.
Top 5 five Indian states with the highest vaccine wastage
Source: MoHFW’s response to Vivek Pandey’s RTI via NDTV
|State||Percentage of vaccine wastage|
The list looks very different from a month ago, when the states with the highest vaccine wastage were Telangana, Andhra Pradesh, Uttar Pradesh, Karnataka and Jammu and Kashmir.
At the time, vaccine wastage in Telangana was as high as 17.6% — higher than Tamil Nadu right now.
Kerala, West Bengal and six other states have no vaccine wastage whatsoever
Eight states were also on the opposite side of the scales. Kerala, West Bengal, Himachal Pradesh, Mizoram, Goa, Daman and Diu, Andaman and Nicobar Islands as well as Lakshadweep had ‘zero wastage’.
When there’s a vaccine shortage, it goes without saying that responsible use is key to ensuring that not a drop goes wasted. And the zero vaccine wastage rates in states like Kerala and West Bengal show that the task is not impossible.
To boost the supply of vaccines in the market, the government has also proposed a 50/50 model. This where half of the supply of Covaxin and Covishield will go directly to the central government, whereas the other half will be available in the open market to private hospitals and state governments.
International players are also free to join the fray with any ‘ready to use’ vaccines. The imports of these vaccines will go into the non-central government route of procurement.
The Serum Institute of India (SII) has reportedly received an advance of ₹3,000 crore from the Indian government to scale up production. Bharat Biotech, which makes Covaxin, has received another ₹1,500 crore.
According to Union Health secretary Rajesh Bhushan, the issue isn’t that there is a shortage of vaccines — despite what some states may claim — but the lack of better planning. “We have made available vaccine doses to states and union territories from time to time and as we told you earlier that to bigger states we give supply of four days at once and on fourth and fifth day we replenish the supply. For smaller states, at once we supply 7-8 days vaccine doses and on the seventh or eighth day their supply is replenished," explained Union Health Secretary Rajesh Bhushan, last week.
SaaS-y salaries are 30% more than traditional IT services — and they’re making it tougher for traditional IT service firms to find the right talent
Tiger Global invests in healthcare startup Pristyn Care, valuation more than doubles in six months
India still has the ‘bad’ classification in the World Press Freedom Index, falls behind Myanmar, Sri Lanka and Nepal
Popular on BI
- Elon Musk sparks another Shiba Inu rally ‘to the moon’ — other Shiba coins follow suit
- A renowned female crime novelist who won a million-euro prize in Spain turned out to be three middle-aged men
- Microsoft President Brad Smith reportedly told Bill Gates more than a decade ago to stop emailing female employees
- Apple MacBook Pro and AirPods 3 launched – Indian pricing, features and everything you need to know
- Apple M1 Pro and M1 Max vs M1: Here’s what Apple improved with its new custom chips
- IRCTC crosses ₹1 lakh crore in market cap for the first time as investors adore its monopoly
- Crypto markets restless as Bitcoin ETF gears up to meet the NYSE tonight
- We aim to be the YouTube of podcasters and scale up 20X in the next 12 months: Sandeep Lodha, Gaana